Skip to main content
Premium Trial:

Request an Annual Quote

Verdezyne Wins $1.7M STTR Grant

NEW YORK (GenomeWeb News) – Verdezyne has received a $1.7 million grant from the National Institute of Allergy and Infectious Diseases that it will use to develop gene libraries for synthetic biology applications in its fermentation development program, the company said today.

The company, which formerly went by the name Coda Genomics, will use the Small Business Technology Transfer grant to fund development of bioinformatics applications for use in its mutant library and synthetic biology programs.

"By advancing this technology, we will be able to utilize the computational tools for improved protein expression and function for our internal biofuel and bio-based chemical programs," Verdezyne Chief Scientific Officer Stephen Picataggio said in a statement.

The firm said that the gene libraries platform it is developing will enhance current metabolic engineering tools.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more